Valuation of biotech/medtech and R&D assets, from discovery to late clinical stage. Strong strategic insight: Asset/company´s stage of readiness - Value of science vs. value of cash - Dealmaking & patterns - Applications: Fundraising; IPO, BD&L partnering, IFRS, US-GAAP, tax-related fairness opinion.

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland